BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15571274)

  • 1. Regulation of equilibrative nucleoside uptake by protein kinase inhibitors.
    Huang M; Wang Y; Mitchell BS; Graves LM
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1445-50. PubMed ID: 15571274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of nucleoside transport by protein kinase inhibitors.
    Huang M; Wang Y; Cogut SB; Mitchell BS; Graves LM
    J Pharmacol Exp Ther; 2003 Feb; 304(2):753-60. PubMed ID: 12538831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.
    Endo Y; Obata T; Murata D; Ito M; Sakamoto K; Fukushima M; Yamasaki Y; Yamada Y; Natsume N; Sasaki T
    Cancer Sci; 2007 Oct; 98(10):1633-7. PubMed ID: 17711502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
    Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
    Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
    Huang M; Wang Y; Collins M; Graves LM
    Leukemia; 2004 Nov; 18(11):1857-63. PubMed ID: 15385935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
    Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep.
    SenGupta DJ; Unadkat JD
    Biochem Pharmacol; 2004 Feb; 67(3):453-8. PubMed ID: 15037197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
    Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
    J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Equilibrative Nucleoside Transporter (ENT1) can be phosphorylated at multiple sites by PKC and PKA.
    Reyes G; Nivillac NM; Karim MZ; Desouza L; Siu KW; Coe IR
    Mol Membr Biol; 2011 Sep; 28(6):412-26. PubMed ID: 21809900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thiazolidinediones on equilibrative nucleoside transporter-1 in human aortic smooth muscle cells.
    Leung GP; Man RY; Tse CM
    Biochem Pharmacol; 2005 Aug; 70(3):355-62. PubMed ID: 15963471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
    Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
    Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
    Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
    Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ.
    Markovic I; Segal M; Djuricic B; Redzic Z
    Exp Physiol; 2008 Mar; 93(3):325-33. PubMed ID: 18039975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells.
    del Santo B; Valdés R; Mata J; Felipe A; Casado FJ; Pastor-Anglada M
    Hepatology; 1998 Dec; 28(6):1504-11. PubMed ID: 9828213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1.
    Chishu T; Sai Y; Nishimura T; Sato K; Kose N; Nakashima E
    Placenta; 2008 May; 29(5):461-7. PubMed ID: 18329095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of nucleoside transport by p38 MAPK inhibitors.
    Huang M; Wang Y; Collins M; Gu JJ; Mitchell BS; Graves LM
    J Biol Chem; 2002 Aug; 277(32):28364-7. PubMed ID: 12077112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
    Bock AJ; Dong HP; Tropé CG; Staff AC; Risberg B; Davidson B
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):467-75. PubMed ID: 21822668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside transporter expression and function in cultured mouse astrocytes.
    Peng L; Huang R; Yu AC; Fung KY; Rathbone MP; Hertz L
    Glia; 2005 Oct; 52(1):25-35. PubMed ID: 15892125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human equilibrative nucleoside transporters by dihydropyridine-type calcium channel antagonists.
    Li RW; Tse CM; Man RY; Vanhoutte PM; Leung GP
    Eur J Pharmacol; 2007 Jul; 568(1-3):75-82. PubMed ID: 17512522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxanthine uptake and release by equilibrative nucleoside transporter 2 (ENT2) of rat microvascular endothelial cells.
    Robillard KR; Bone DB; Hammond JR
    Microvasc Res; 2008 Apr; 75(3):351-7. PubMed ID: 18048066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.